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RRadiofrequency catheter ablation is a well established modality of treatment for ventricular 
tachycardia (VT). But it may not be successful in certain cases when the re-entrant circuit is 
situated deep within the myocardium and inaccessible to both endocardial and epicardial ablation. 
One of the earliest reports on transcoronary ethanol ablation of refractory ventricular tachycardia 
was by Inoue H et al in 1987 [1] in experimental animals followed by Brugada P et al in humans 
in 1989 [2]. Brugada P et al identified the artery supplying the arrhythmogenic area and injected 
1.5-6ml of sterile 96% ethanol, which cured the arrhythmia in two of the three patients. In the 
third   one,   arrhythmia   recurred   when   a   new   collateral   blood   supply   developed   to   the 
arrhythmogenic region, which was successfully treated by a repeat procedure. They had done a 
careful transcoronary mapping with saline prior to ablation in all cases. One of their patients 
developed temporary complete atrioventricular block after high septal ethanol ablation, requiring 
pacemaker.
Qi XQ et al [3] also reported successful transcoronary ethanol ablation in a patient with refractory 
ventricular tachycardia, who had no recurrence at two year follow up. They had demonstrated 
similar results in experimental animals earlier [4]. de Paola AA et al [5] documented ethanol 
ablation of ventricular tachycardia in chronic chagasic myocarditis. Programmed ventricular 
stimulation done after two weeks failed to induce ventricular tachycardia in their case. Nellens P 
et   al   [6]   identified   the   culprit   vessel   by   a   combination   of   coronary   angiography,   left 
ventriculography,   programmed   electrical   stimulation   with   endocardial   mapping   and   pace 
mapping. Ethanol ablation was successful in all the ten of the twelve cases in which the artery 
could be identified. Six of them remained free of tachycardia and seven of them were alive, at a 
follow up period ranging from 2 to 44 months.                                                                       
 
Verna E et al [7] described a case of fatal myocardial rupture and cardiac tamponade following 
successful alcohol ablation of refractory ventricular tachycardia and advised caution while 
proceeding  with alcohol  ablation.                                                                            
Recent reports by  Sacher F et al [8] and Tokuda M et al [9] have once again highlighted the role 
of transcoronary ethanol ablation of refractory ventricular tachycardia after failed radiofrequency 
catheter ablation. Most of these were in the setting of ischemic cardiomyopathy with scar related 
re-entry. Reports  of  successful  transcoronary  ethanol  ablation  in  ventricular  tachycardias  in 
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hypertrophic cardiomyopathy [10] and ventricular tachycardia arising from the aortomitral 
continuity [11] are also available. Overall data would suggest that transcoronary ethanol ablation 
may be considered in refractory ventricular tachycardias which are not amenable to conventional 
radiofrequency catheter ablation due to deep seated foci of origin.                                     
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